New "IL-17A in Psoriasis" Resource Launches on epgonline.org

London, United Kingdom, September 26, 2015 --(PR.com)-- A new educational resource has launched on epgonline.org to provide healthcare professionals with information on the impact of IL-17A in psoriasis. This resource is intended for all healthcare professionals interested or involved in the management of psoriasis.

Psoriasis is a chronic inflammatory disease, with a prevalence of 2% in both Europe and North America.1 It is one of the most common skin conditions with a wide range of clinical manifestations.1 In the majority of cases psoriasis presents with disfiguring, scaling and erythematous plaques on the skin. Psoriasis impacts severely on patient quality of life, which can be further worsened by certain treatments.2

The IL-17A in Psoriasis resource has been developed to provide information and education on psoriasis pathophysiology and treatment. This resource offers a wealth of educational content that discusses the role of the IL-17 pathway in the pathogenesis of psoriasis and the therapeutic potential of treatments directed towards IL-17A. Users can find videos from leading experts, clinical presentations, content from international congresses, key publications and links to useful external resources. To access this resource for free please go to: http://www.epgonline.org/psoriasis-knowledge-centre/IL17A-in-psoriasis/. ‘IL-17A in Psoriasis’ is located within the Psoriasis Knowledge Centre of epgonline.org which can be accessed here: http://www.epgonline.org/psoriasis-knowledge-centre/.

“The IL-17A in Psoriasis area provides a valuable addition to epgonline.org,” said Dr Toby Galbraith, Director of Content Strategy for epgonline.org. “The latest resources from scientific meetings, expert video insights and analysis of the potential of targeting the IL-17A pathway make this a key area for psoriasis physicians to visit.” The IL-17A in Psoriasis area is produced in collaboration with Novartis Pharma AG.

Notes to Editors:

· EPG Health Media (Europe) Ltd publishes www.epgonline.org, an independent website dedicated to providing healthcare professionals worldwide with free access to a comprehensive range of disease and medicines information. Categorised by medical specialty, content within epgonline.org includes a multi-language database of approved medications, treatment guidelines, clinical trial reports, journal abstracts, latest medical industry news, apps and a blog written by members.

References:

1. Boehncke W-F, Boehncke S. More than skin-deep: the many dimensions of psoriatic disease. Swiss Med Wkly. 2014;144:w13968.
2. Cohen SN, Baron SE, Archer CB. Guidance on the diagnosis and clinical management of psoriasis. Clin Experiment Dermatol. 2012;37(Suppl 1):13-8.